Safety of Fexofenadine during pregnancy and lactation

Fexofenadine during pregnancy and lactation, Fexofenadine category by FDA, its use during pregnancy and lactation its teratogenic effects are described.

Small amount of drug excrete into breast milk, if required low dose should be prescribed.

Fexofenadine  during pregnancy and lactation
Pregnancy	Category  C      ( by FDA ) Category B       ( AU TGA )
	Fexofenadine crosses the placenta, as limited number of studies available with use of this drug, use Fexofenadine only when benefit overweigh the risk, animal studies failed to reveal evidence of teratogenicity.
Breast feeding	Fexofenadine excretes into breastmilk in small quantities, effect on nursing infant unknown hence not recommened.